Services
InSilicoTrials' Services
Hyper-accelerate drug and medical device development
Services for Pharma
The conventional drug development approach is an expensive and time-consuming process, but with the help of mathematical modeling and computational drug design approaches these challenges can be overcome.
With a wide range of extensively validated models and a professionally strong and highly experienced in-house R&D team, we provide strategic consulting services to maximize the impact of each study on the entire drug development cycle.
Services for MedTech
We enable scientists and engineers to simulate the performance of medical devices and therapies in a low-risk, cost-effective virtual environment. Analyzing hypothesis, validating ideas and testing against standards can now happen in a faster and safer way.
With a wide range of extensively validated models and a professionally strong and highly experienced in-house R&D team, we provide strategic consulting services to maximize your outcomes.
Expert support in line with regulatory requirements
The life science industry has long faced the lengthy and costly process of developing new drugs and medical devices: Digital Twin and Biosimulation are the key to cutting down time frames and costs in this area, with two trends pushing heavily in this direction: the regulatory tailwind (both the FDA and EMA are already endorsing these technologies) and the disruption the pandemic caused in pharma and Medtech R&D, paving the way to a new trial paradigm.
InSilicoTrials has considerable experience with regulatory agencies around the globe such as EMA and the FDA. We can therefore support our clients in their regulatory processes and ensure the documentation presented on their pathway towards compliance is scientifically focused and practical.